Derivatives of dihydroxypyrrolidine as anti- cancer compounds

The present invention relates to derivatives of dihydroxypyrrolidine useful in the treatment of cancer. The invention further relates to a process for making the compounds. The compounds are inhibitors of alpha mannosidase, and possibly, also inhibit nicotinamide phosphoribosyl transferase.


Year:
2009
Other identifiers:
TTO: 6.0764.1
EPO Family ID: 39672627
Laboratories:




 Record created 2015-09-22, last modified 2018-09-13


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)